| CASE REPORT |
|
| Year : 2010 | Volume
: 28
| Issue : 2 | Page : 173-176 |
Mycobacterium arupense pulmonary infection: Antibiotic resistance and restriction fragment length polymorphism analysis
IK Neonakis1, Z Gitti1, F Kontos2, S Baritaki3, E Petinaki4, M Baritaki1, V Liakou5, L Zerva2, DA Spandidos6
1 Mycobacteriology Laboratory, Department of Clinical Bacteriology, Parasitology, Zoonoses and Geographical Medicine, University Hospital of Heraklion, Heraklion, Greece
2 Clinical Microbiology Laboratory, Medical School of Athens, "Attikon" University Hospital, Athens, Greece
3 Department of Laboratory Medicine, School of Medicine, University of Crete, Heraklion, Greece
4 Department of Microbiology, School of Medicine, University of Thessaly, Larissa, Greece
5 Department of Microbiology, "Venizeleion" General Hospital, Heraklion, Greece
6 Mycobacteriology Laboratory, Department of Clinical Bacteriology, Parasitology, Zoonoses and Geographical Medicine, University Hospital of Heraklion, Heraklion; Department of Laboratory Medicine, School of Medicine, University of Crete, Heraklion, Greece
Correspondence Address:
I K Neonakis
Mycobacteriology Laboratory, Department of Clinical Bacteriology, Parasitology, Zoonoses and Geographical Medicine, University Hospital of Heraklion, Heraklion
Greece
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0255-0857.62502
Mycobacterium arupense is a novel mycobacterium species. It was first identified from clinical specimens in 2006 and since then there have been only two reports of its recovery from clinical samples. In the present case M. arupense was isolated from the sputum of a 62-year-old man with a malignant mass in his left kidney, who presented with a one-month history of recurrent fever, dyspnea and haemoptysis. M. arupense was identified with sequencing of hsp65 and 16S rRNA genes. In the present study, its biochemical profile along with its resistance status and hsp65 RFLP analysis is presented.
[FULL TEXT] [PDF]*
|
